Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 82 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

12%

10 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

35 recruiting

Enrollment Performance

Analytics

N/A

30(55.6%)

Phase 2

13(24.1%)

Phase 3

7(13.0%)

Phase 4

3(5.6%)

Early Phase 1

1(1.9%)

54Total

N/A(30)

Phase 2(13)

Phase 3(7)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (82)

Showing 20 of 82 trials

NCT07856355Phase 4Not Yet Recruiting

Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

Role: collaborator

NCT03957707Not ApplicableCompleted

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: collaborator

NCT05759572Phase 2Active Not Recruiting

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Role: collaborator

NCT06218485Not ApplicableActive Not Recruiting

FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease

Role: collaborator

NCT05923489Not ApplicableRecruiting

Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

Role: collaborator

NCT07304934Recruiting

A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer

Role: collaborator

NCT07735182Recruiting

Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury

Role: collaborator

NCT07724587Not ApplicableRecruiting

The Effectiveness and Safety of Combined Research on Uremic Sarcopenia

Role: lead

NCT07722286Completed

Relapse and Functional Outcomes in Anti-LGI1 Encephalitis

Role: collaborator

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07670013Phase 2Recruiting

SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT04513418Phase 3Active Not Recruiting

Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

Role: collaborator

NCT07616518Not Yet Recruiting

Dynamic Trajectories of Pupillary Light Reflex Parameters and Prognosis in Critically Ill Patients: A Multicenter Prospective Cohort Study

Role: collaborator

NCT07604350Phase 3Not Yet Recruiting

Edaravone Dexborneol for Post-Stroke Epilepsy

Role: collaborator

NCT07572708Not ApplicableNot Yet Recruiting

Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Role: lead

NCT07553767Early Phase 1Not Yet Recruiting

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Role: collaborator

NCT07548281Not ApplicableNot Yet Recruiting

Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

Role: collaborator

NCT07542002Phase 2Recruiting

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Role: lead

NCT05738642Not ApplicableCompleted

Efficacy and Safety of Early Use PCC in Severe Trauma

Role: collaborator